Objectives: Recent studies have shown that patients with uncomplicated acute type B aortic dissection (uATBAD) who have enlarged descending thoracic aortic diameters are at high risk of developing complications. This study aimed to determine the effect of maximum ascending aortic diameter and area on outcomes in patients with uATBAD.
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Objectives: This study assessed in-hospital mortality and midterm results of emergency thoracic endovascular aortic repair (TEVAR) stent grafting for patients with life-threatening complications of acute type B aortic dissections (acTBD). March 2001 and Sept 2016, 53 patients (38 men; mean age, 55 6 13) with an acTBD were treated with TEVAR for malperfusion (55%), aortic rupture (15%), or persistent untreatable pain (30%) as a sign of pending rupture. Four patients (8%) had undergone previous aortic surgery.
Methods: Between
Results: Technical success (coverage of the primary tear site) was achieved in 48 patients (91%). Overall hospital mortality rate was 9% (n ¼ 5). Causes of death were rupture during the procedure or on the first postinterventional day in two patients and redissection (ascending aorta n ¼ 2, descending aorta n ¼ 1) with consequent aortic rupture after TEVAR in the remaining three. Permanent neurologic dysfunction occurred in 3 patients (stroke n ¼ 1, paraplegia n ¼ 2). Nineteen patients (36%) developed early endoleaks (type Ia, n ¼ 5; type Ib, n ¼ 11; type II, n ¼ 2; type Ib plus II, n ¼ 1) and were observed throughout the postinterventional period. These seven patients (37%) needed secondary endovascular intervention (n ¼ 3) or conventional surgery (n ¼ 4) due to aortic progression (mean interval after procedure 92 6 56 months). Secondary endoleaks were observed in nine patients with consequent reintervention in three patients. The actuarial survival was 88%, 76%, and 58% at 1, 5, and 10 years, respectively. Freedom from treatment failure at 1, 5, and 10 years (including reintervention, aortic rupture, device-related complications, aortic-related death, or sudden, unexplained late death) was 76 %, 74%, and 74%, respectively.
Conclusions: TEVAR in the treatment of acute complicated type B aortic dissection proves to be an excellent treatment modality in this high risk patient cohort. Refinements, especially in stent design and application, may further reduce the rate of endoleaks and improve the prognosis of patients in this life-threatening situation.
Author Disclosures: D. Beitzke: Nothing to disclose; M. P. Ehrlich: Nothing to disclose; M. Funovic: Nothing to disclose; G. Laufer: Nothing to disclose; C. Loewe: Nothing to disclose; S. MaHR, Nothing to disclose; M. Stelzmueller: Nothing to disclose; F. Wolf: Nothing to disclose.
PC024.
Results Objectives: This study evaluated the outcomes from a postmarket registry of the Zenith Spiral-Z AAA Iliac Leg Graft (Spiral-Z leg graft) with a continuous, spiral nitinol stent that was designed for improved conformability, kink, and migration resistance.
Methods: This prospective, multicenter registry was designed to evaluate the outcomes of the Spiral-Z leg graft in up to 600 patients who underwent EVAR at up to 30 sites in the United States and Canada. Patients were enrolled between March 2012 and March 2015. Main study outcomes were iliac limb occlusion, limb-related reintervention, limb-related endoleak, component separation, and device integrity. Short-term data were collected during an interval of 1 to 6 months with longer-term data collected at 12 months.
Results: Among 592 study patients (mean age 74 6 8 years; 87% male; 26% with aortoiliac aneurysm), Spiral-Z leg grafts were placed in 1151 limbs with subsequent Spiral-Z leg extensions used in 102 limbs. The mean iliac diameters were 9 6 4 mm (left) and 9 6 3 mm (right), and moderate/severe occlusive disease, calcification, and vessel tortuosity were present in 14%, 25%, and 36% (left) and 16%, 25%, and 34% (right), respectively, of iliac arteries. Adjunctive intraoperative iliac artery procedures (iliac artery angioplasty and/or stent placement) were performed in 119 patients (20%; bilateral in 57 patients). Mortality within 30 days was 1.5% (9 of 592); cumulative mortality at 365 days was 5.9% (35 of 592). There were no aortic ruptures, but one open conversion (0.2%). Limb occlusions occurred in 11 patients (1.9%; 3 within and 8 after 30 days; all unilateral; none had received procedural iliac artery adjuncts at implantation); of these, seven patients underwent reinterventions. An additional eight patients underwent limb-related reinterventions for nonocclusive kink, compression, or thrombus (6 within and 2 after 30 days). In total, 14 patients (2.4%) underwent 15 limb-related reinterventions (7 for occlusions and 8 for nonocclusive causes); eight of these 15 reinterventions occurred within 1 week of the index procedure. One
